Raymond James reiterates Strong Buy on Peapack-Gladstone stock By Investing.com

Peapack-Gladstone received a $50M preferred stock commitment (initial $30M private placement with an option for an additional $20M through 2027) featuring a 6.00% annual dividend and non-callable for five years, which Raymond James views favorably and maintained a Strong Buy with a $39 price target. The company will redeem $100M of subordinated notes due Dec 22, 2030 at 100% of principal plus accrued interest and expects the transaction to improve capital ratios while causing ~1% net EPS dilution in 2026. Shares trade at $34.74, up ~24% YTD and near a 52-week high of $35.87; the preferred issuance and redemption are framed as strengthening capital and retention via performance-based RSUs to executives through 2028.

Analysis

Peapack-Gladstone’s capital reshuffle effectively shifts risk from fixed‑income creditors to hybrid/equity holders, which should lift regulatory capital ratios and give management more optionality for loan growth or buybacks over the next 12–24 months. Second‑order, that lower interest‑bearing debt profile reduces volatility in net interest expense, making forward NIM guidance more sensitive to deposit repricing and loan mix rather than financing costs.

Regional peers that still carry heavy subordinated debt will face relative funding pressure: investors may bid up hybrids and convertibles across the group, compressing yields and prompting refinancing activity that narrows spreads for those banks. Strategic investors who take anchor positions in regionals gain leverage over governance and M&A cadence — expect more consensual consolidation conversations in the 6–18 month window.

Key risks are macro and structural: an abrupt deposit flight or a sharp widening of regional bank credit spreads would negate the capital cushion benefits and could force equity dilution if hybrids convert under distress. Near‑term catalysts to monitor are quarter‑over‑quarter loan growth, provisioning cadence, and any change in the conversion/redemption timetable — each can swing sentiment quickly over 30–90 days.

Contrarian angle: the market’s upbeat read on capital improvement may underprice conversion timing and implied leverage shift to common shareholders; if credit costs tick up, that positive read-through reverses faster than usual for small-regionals. The prudent stance is constructive but sized and hedged — treat this as an idiosyncratic capital-structure reflation trade, not a pure sector directional call.

Key Decisions for Investors

• Long PGC common (size 2–4% portfolio). Entry on weakness up to -10% from current levels; target 12‑month upside +25–35%, hard stop at -12% intraday. Rationale: capture re-rating as capital mix benefits ROE while keeping position size manageable for execution risk.
• Bull-call spread on PGC (9–12 month): buy 1 near-the-money call, sell 1 25–35% OTM call to finance. Cost ~20–30% of notional with max upside ~200–300% if stock re-rates; limited downside to premium paid — deploy if you want convexity with defined loss.
• Relative trade: go long PGC / short KRE (dollar neutral, 1:1) for 3–6 months. Expect PGC to outperform by 250–500 bps as company-specific capital actions outpace sector; risk is systemic regional stress where pair could materially underperform.
• Protective hedge: buy 6–9 month PGC puts 12–18% OTM sized to cover 50% of long exposure. Cost is insurance against accelerated credit or deposit shocks that would erase re-rating benefits in 30–90 days.